Hans-Joerg Senn
- Cancer Research top 2%
- Breast Cancer Treatment Studies 3
- Oncology top 5%
- Neutropenia and Cancer Infections 6
- Cancer Treatment and Pharmacology 3
- Genetics top 5%
- Blood disorders and treatments 3
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation 3
-
- Acute Myeloid Leukemia Research 2
-
- Nausea and vomiting management 5
-
- Hematological disorders and diagnostics 4
- Co-authors
- Beat ThürlimannRichard D. GelberAron GoldhirschAlan S. CoatesJohn H. GlickJames F. HollandTarit K. BanerjeeP Alberto
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (1 paper)Blood (1 paper)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Hans-Joerg Senn
25 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 649
- Oncology 733
- Genetics 359
- Pathology and Forensic Medicine 214
- Hematology 57
Countries citing papers authored by Hans-Joerg Senn
This map shows the geographic impact of Hans-Joerg Senn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans-Joerg Senn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans-Joerg Senn more than expected).
Fields of papers citing papers by Hans-Joerg Senn
This network shows the impact of papers produced by Hans-Joerg Senn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans-Joerg Senn. The network helps show where Hans-Joerg Senn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans-Joerg Senn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 17 | |
| 2 | 2008 | 0 | |
| 3 | 2006 | 18 | |
| 4 | Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005breakdown → | 2005 | 886 |
| 5 | 1998 | 35 | |
| 6 | 1992 | 33 | |
| 7 | 1991 | 7 | |
| 8 | [Does post-puncture syndrome following lumbar puncture depend on needle diameter?]. | 1989 | 3 |
| 9 | [Malignant pericardial effusion--a sign of unfavorable prognosis?]. | 1986 | 3 |
| 10 | [Metoclopramide plasma levels following oral administration of high doses for prophylaxis of emesis in cytostatic therapy]. | 1984 | 1 |
| 11 | 1978 | 1 | |
| 12 | 1976 | 13 | |
| 13 | 1974 | 16 | |
| 14 | 1974 | 8 | |
| 15 | 1974 | 32 | |
| 16 | 1973 | 1 | |
| 17 | [The significance of bone marrow and liver puncture in malignant lymphomas]. | 1972 | 2 |
| 18 | 1972 | 22 | |
| 19 | 1972 | 71 | |
| 20 | [Clinical diagnosis of amyloidosis]. | 1966 | 0 |
About Hans-Joerg Senn
Hans-Joerg Senn is a scholar working on Oncology, Hematology and Emergency Medicine, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (6 papers), Nausea and vomiting management (5 papers), Hematological disorders and diagnostics (4 papers), Blood disorders and treatments (3 papers), Cancer Treatment and Pharmacology (3 papers), Breast Cancer Treatment Studies (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Cancer Research (649 citations), Oncology (733 citations) and Genetics (359 citations). Hans-Joerg Senn has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Beat Thürlimann, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, John H. Glick, James F. Holland, Tarit K. Banerjee, P Alberto, W. Rhomberg and William P. Peters. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.